dc.contributor.author
Schirm, Sibylle
dc.contributor.author
Nouailles, Geraldine
dc.contributor.author
Kirsten, Holger
dc.contributor.author
Trimpert, Jakob
dc.contributor.author
Wyler, Emanuel
dc.contributor.author
Teixeira Alves, Luiz Gustavo
dc.contributor.author
Landthaler, Markus
dc.contributor.author
Ahnert, Peter
dc.contributor.author
Suttorp, Norbert
dc.contributor.author
Witzenrath, Martin
dc.contributor.author
Scholz, Markus
dc.date.accessioned
2025-01-29T09:55:53Z
dc.date.available
2025-01-29T09:55:53Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/46414
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-46127
dc.description.abstract
When infected with SARS-CoV-2, Syrian hamsters (Mesocricetus auratus) develop moderate disease severity presenting key features of human COVID-19. We here develop a biomathematical model of the disease course by translating known biological mechanisms of virus-host interactions and immune responses into ordinary differential equations. We explicitly describe the dynamics of virus population, affected alveolar epithelial cells, and involved relevant immune cells comprising for example CD4+ T cells, CD8+ T cells, macrophages, natural killer cells and B cells. We also describe the humoral response dynamics of neutralising antibodies and major regulatory cytokines including CCL8 and CXCL10. The model is developed and parametrized based on experimental data collected at days 2, 3, 5, and 14 post infection. Pulmonary cell composition and their transcriptional profiles were obtained by lung single-cell RNA (scRNA) sequencing analysis. Parametrization of the model resulted in a good agreement of model and data. The model can be used to predict, for example, the time course of the virus population, immune cell dynamics, antibody production and regeneration of alveolar cells for different therapy scenarios or after multiple-infection events. We aim to translate this model to the human situation in the future.
en
dc.format.extent
18 Seiten
dc.rights
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
Mathematical model
en
dc.subject
Immune response
en
dc.subject
Natural killer cells
en
dc.subject
Neutralising antibodies
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::616 Krankheiten
dc.title
A biomathematical model of SARS-CoV-2 in Syrian hamsters
dc.type
Wissenschaftlicher Artikel
dc.date.updated
2025-01-28T06:56:34Z
dcterms.bibliographicCitation.articlenumber
30541
dcterms.bibliographicCitation.doi
10.1038/s41598-024-80498-9
dcterms.bibliographicCitation.journaltitle
Scientific Reports
dcterms.bibliographicCitation.number
1
dcterms.bibliographicCitation.volume
14
dcterms.bibliographicCitation.url
https://doi.org/10.1038/s41598-024-80498-9
refubium.affiliation
Veterinärmedizin
refubium.affiliation.other
Institut für Virologie
![This authority value has been confirmed as accurate by an interactive user](/cache_0fdaa16ecf2e120b3856a5a937c7ad56/themes/FuCD/images/authority_control/invisible.gif)
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.isPartOf.eissn
2045-2322
refubium.resourceType.provider
DeepGreen